What are the best treatments for BPES - Blepharophimosis Ptosis Epicanthus Inversus Syndrome?

TL;DR: Treatment for Blepharophimosis Ptosis Epicanthus Inversus Syndrome (BPES) is primarily surgical, focusing on correcting eyelid architecture and function to prevent vision-related complications like amblyopia. While there is no medication to cure BPES, a multidisciplinary approach involving specialized surgeons is essential to manage the distinct physical features of the syndrome.

How is BPES treated surgically?

Because Blepharophimosis Ptosis Epicanthus Inversus Syndrome is a congenital structural condition, surgery is the gold standard for treatment. Procedures are typically performed in two stages. The first stage often addresses the epicanthus inversus (the skin folds) and telecanthus (wide-set inner corners of the eyes). The second stage, usually performed several months later, addresses the ptosis (drooping eyelids) to ensure proper vision development. Surgical timing is critical to prevent "lazy eye" (amblyopia) in children diagnosed with BPES.

Which specialists should be on the care team?

Managing Blepharophimosis Ptosis Epicanthus Inversus Syndrome requires a collaborative, multidisciplinary care team to address both functional and aesthetic concerns. Essential specialists often include:

• Oculoplastic Surgeon: Experts in the complex reconstruction of the eyelids.


• Pediatric Ophthalmologist: To monitor visual development and manage amblyopia or refractive errors.


• Clinical Geneticist: To provide counseling regarding the FOXL2 gene mutation associated with BPES.


• Psychologist: To support patients and families dealing with the psychosocial impacts of facial differences.

Is there medication for BPES?

There are currently no pharmacological treatments or medications that can correct the anatomical features of Blepharophimosis Ptosis Epicanthus Inversus Syndrome. Medical management is strictly supportive, focusing on lubricating eye drops or ointments if the eyelids do not close fully, which can lead to corneal exposure. Treatment effectiveness varies significantly between patients, and outcomes depend heavily on the severity of the ptosis and the timing of surgical interventions.

Are there emerging research developments?

Research into Blepharophimosis Ptosis Epicanthus Inversus Syndrome currently focuses on better understanding the FOXL2 gene's role in ovarian development, as some females with BPES Type I experience premature ovarian insufficiency. Clinical studies are ongoing to improve surgical techniques that minimize scarring and optimize long-term ocular alignment.

Next steps

• Consult with a board-certified oculoplastic surgeon experienced in complex congenital eyelid reconstruction.


• Connect with the 70 members of the DiseaseMaps.org community living with Blepharophimosis Ptosis Epicanthus Inversus Syndrome to share experiences.


• Schedule a comprehensive eye exam to rule out amblyopia or astigmatism.


• Request a referral to a geneticist for comprehensive family planning and syndrome-specific screening.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult your personal healthcare team for diagnosis and treatment decisions.

References

• NIH Genetic and Rare Diseases Information Center (GARD): BPES Overview.


• Orphanet: Blepharophimosis-ptosis-epicanthus inversus syndrome (ORPHA:127).


• OMIM (Online Mendelian Inheritance in Man): Entry #110100 (BPES).


• National Eye Institute: Information on Congenital Ptosis.